Conventional and future diagnostics for avian influenza

Bruce Charlton, Beate Crossley, Sharon Hietala

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

The significant and continued transboundary spread of Asian avian influenza H5N1 since 2003, paired with documented transmission from avian species to humans and other mammals, has focused global attention on avian influenza virus detection and diagnostic strategies. While the historic and conventional laboratory methods used for isolation and identification of the virus and for detection of specific antibodies continued to be widely applied, new and emerging technologies are rapidly being adapted to support avian influenza virus surveillance and diagnosis worldwide. Molecular tools in particular are advancing toward lab-on-chip and fully integrated technologies that are capable of same day detection, pathotyping, and phylogenetic characterization of influenza A viruses obtained from clinical specimens. The future of avian influenza diagnostics, rather than moving toward a single approach, is wisely adopting a strategy that takes advantage of the range of conventional and advancing technologies to be used in "fit-for-purpose" testing.

Original languageEnglish (US)
Pages (from-to)341-350
Number of pages10
JournalComparative Immunology, Microbiology and Infectious Diseases
Volume32
Issue number4
DOIs
StatePublished - Jul 2009

Fingerprint

Influenza in Birds
avian influenza
Influenza A virus
Orthomyxoviridae
Technology
laboratory techniques
mammals
Mammals
viruses
antibodies
monitoring
phylogeny
Viruses
Antibodies
testing

Keywords

  • "Fit-for-purpose"
  • Avian influenza
  • Detection
  • Diagnosis

ASJC Scopus subject areas

  • Immunology
  • Microbiology
  • Infectious Diseases
  • Immunology and Allergy
  • veterinary(all)

Cite this

Conventional and future diagnostics for avian influenza. / Charlton, Bruce; Crossley, Beate; Hietala, Sharon.

In: Comparative Immunology, Microbiology and Infectious Diseases, Vol. 32, No. 4, 07.2009, p. 341-350.

Research output: Contribution to journalArticle

@article{973e72669e9f40b3915a81dd36eea658,
title = "Conventional and future diagnostics for avian influenza",
abstract = "The significant and continued transboundary spread of Asian avian influenza H5N1 since 2003, paired with documented transmission from avian species to humans and other mammals, has focused global attention on avian influenza virus detection and diagnostic strategies. While the historic and conventional laboratory methods used for isolation and identification of the virus and for detection of specific antibodies continued to be widely applied, new and emerging technologies are rapidly being adapted to support avian influenza virus surveillance and diagnosis worldwide. Molecular tools in particular are advancing toward lab-on-chip and fully integrated technologies that are capable of same day detection, pathotyping, and phylogenetic characterization of influenza A viruses obtained from clinical specimens. The future of avian influenza diagnostics, rather than moving toward a single approach, is wisely adopting a strategy that takes advantage of the range of conventional and advancing technologies to be used in {"}fit-for-purpose{"} testing.",
keywords = "{"}Fit-for-purpose{"}, Avian influenza, Detection, Diagnosis",
author = "Bruce Charlton and Beate Crossley and Sharon Hietala",
year = "2009",
month = "7",
doi = "10.1016/j.cimid.2008.01.009",
language = "English (US)",
volume = "32",
pages = "341--350",
journal = "Comparative Immunology, Microbiology and Infectious Diseases",
issn = "0147-9571",
publisher = "Elsevier Limited",
number = "4",

}

TY - JOUR

T1 - Conventional and future diagnostics for avian influenza

AU - Charlton, Bruce

AU - Crossley, Beate

AU - Hietala, Sharon

PY - 2009/7

Y1 - 2009/7

N2 - The significant and continued transboundary spread of Asian avian influenza H5N1 since 2003, paired with documented transmission from avian species to humans and other mammals, has focused global attention on avian influenza virus detection and diagnostic strategies. While the historic and conventional laboratory methods used for isolation and identification of the virus and for detection of specific antibodies continued to be widely applied, new and emerging technologies are rapidly being adapted to support avian influenza virus surveillance and diagnosis worldwide. Molecular tools in particular are advancing toward lab-on-chip and fully integrated technologies that are capable of same day detection, pathotyping, and phylogenetic characterization of influenza A viruses obtained from clinical specimens. The future of avian influenza diagnostics, rather than moving toward a single approach, is wisely adopting a strategy that takes advantage of the range of conventional and advancing technologies to be used in "fit-for-purpose" testing.

AB - The significant and continued transboundary spread of Asian avian influenza H5N1 since 2003, paired with documented transmission from avian species to humans and other mammals, has focused global attention on avian influenza virus detection and diagnostic strategies. While the historic and conventional laboratory methods used for isolation and identification of the virus and for detection of specific antibodies continued to be widely applied, new and emerging technologies are rapidly being adapted to support avian influenza virus surveillance and diagnosis worldwide. Molecular tools in particular are advancing toward lab-on-chip and fully integrated technologies that are capable of same day detection, pathotyping, and phylogenetic characterization of influenza A viruses obtained from clinical specimens. The future of avian influenza diagnostics, rather than moving toward a single approach, is wisely adopting a strategy that takes advantage of the range of conventional and advancing technologies to be used in "fit-for-purpose" testing.

KW - "Fit-for-purpose"

KW - Avian influenza

KW - Detection

KW - Diagnosis

UR - http://www.scopus.com/inward/record.url?scp=62549105359&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=62549105359&partnerID=8YFLogxK

U2 - 10.1016/j.cimid.2008.01.009

DO - 10.1016/j.cimid.2008.01.009

M3 - Article

VL - 32

SP - 341

EP - 350

JO - Comparative Immunology, Microbiology and Infectious Diseases

JF - Comparative Immunology, Microbiology and Infectious Diseases

SN - 0147-9571

IS - 4

ER -